MedPath

Effect of nasal administration of brahmi ghritha on cognitive functions and mode of action of nasal medication with Brahmi ghritha

Phase 3
Registration Number
CTRI/2020/03/024148
Lead Sponsor
Shilpa S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Healthy male volunteers between 20-40 age group with BMI 18.5 â?? 24.9

2. Nasya Arha as per ayurveda texts

3. Healthy volunteers as determined by screening assessments and Principle investigatorâ??s judgement

Exclusion Criteria

1. Known case of Hypersensitivity to nasal medications

2. Persons under regular and frequent medication for any physical or mental illness

3. History of alcoholism, tobacco intake since 6 months

4. Clinically relevant history of disease related to respiratory, gastro intestinal, cardiovascular, neurological, renal, hepatic and hematological systems

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Assessment of cognitive function with Addenbrookes Cognitive Examination - ACE-III Indian English and on 0th day and 7th day of brahmi ghritha nasya <br/ ><br>2.Identification of bacoside A in blood plasma after nasya karma using HPLC method on 7th day of therapy <br/ ><br>Timepoint: 1.Assessment of cognitive function with Addenbrookes Cognitive Examination - ACE-III Indian English and on 0th day and 7th day of brahmi ghritha nasya <br/ ><br>2.Identification of bacoside A in blood plasma after nasya karma using HPLC method on 7th day of therapy <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
ot applicableTimepoint: Not applicable
© Copyright 2025. All Rights Reserved by MedPath